NCT04691726View on ClinicalTrials.gov

Impact of Intra- and Postoperative Continuous Infusion of Lidocaine on Analgesia in Vascular Anaesthesia

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 29, 2019

Primary Completion Date

June 3, 2022

Study Completion Date

July 2, 2022

Conditions

Abdominal Aorta AneurysmAbdominal Aorta AtheromaSurgeryPain, Postoperative

Interventions

DRUG

lidocaine 10mg/ml

bolus i.v. + continuous i.v. infusion

DRUG

Placebo

bolus i.v. + continuous i.v. infusion

DRUG

Metamizole

2,5 g i.v. BD

DRUG

Morphine

continuous i.v. infusion adjusted to VAS scale score

Trial Locations (1)

40-635

Leszek Giec Upper-Silesia Medical Center of the Medical University of Silesia in Katowice, Katowice

All Listed Sponsors

lead

Łukasz Krzych

OTHER

NCT04691726 - Impact of Intra- and Postoperative Continuous Infusion of Lidocaine on Analgesia in Vascular Anaesthesia | Biotech Hunter | Biotech Hunter